IP Library Granted Patent US 10,017,830
Granted Patent B2
US 10,017,830 · App. 14/286,402 · Granted Jul 10, 2018

Oligonucleotide probes, kit containing the same and method for pathotyping of H5 avian influenza viruses

Inventors: Lih-Chiann Wang (Taipei, TW); Chien-Hao Huang (Taipei, TW); Ching-Ho Wang (Taipei, TW)
Assignee: National Taiwan University
C12Q1/701
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,017,830
App. No.
14/286,402
Granted
Jul 10, 2018
Kind
B2
Abstract

The present invention provides a group of specific probes directed to cleavage site of hemagglutinin precursor protein of avian influenza virus subtypes H5, and provides a method for rapid pathotyping of H5 avian influenza virus. The present invention further provides a kit containing the probes and the kit is easy-to-use, low-cost, high sensitivity, enabled the molecular pathotyping of H5 viruses by a simpler and faster means that conventional methods.

Claims (20)

1. A microarray for detecting H5 avian influenza virus and pathotyping the detected H5 avian influenza virus as a low-pathogenic avian influenza virus (LPAIV) or a highly-pathogenic avian influenza virus (HPAIV), comprising the following probes (i) to (v):

(i) at least one probe comprising the nucleotide sequence of 5′-GAATGYCCCARATAYGTGAAAT-3′ (SEQ ID NO: 2);

(ii) at least one probe comprising the nucleotide sequence of 5′-CCYCARATAGARACAAGR-3′ (SEQ ID NO: 3);

(iii) at least one probe comprising the nucleotide sequence of 5′-CCYCAR AGAGARACRAGA-3′ (SEQ ID NO: 5);

(iv) at least one probe comprising the nucleotide sequence of 5′-MGAGAAAAAAGAGGMCTA-3′ (SEQ ID NO: 10); and

(v) at least one probe comprising the nucleotide sequence of 5′-CCYCAAAGRARRAAAAGA-3′ (SEQ ID NO: 12);

wherein each of probes (i) to (v) have a tail composed of 19T bases added on their 5′ end; and

wherein Y is C or T, M is A or C, R is A or G, and S is C or G.

2. A kit comprising the microarray defined in claim 1 .

3. The microarray of claim 1 , further comprising a positive control probe comprising the nucleotide sequence of SEQ ID NO: 14; wherein the positive control probe has a tail composed of 19T bases added on its 5′ end.

4. The microarray of claim 1 , wherein the microarray further comprises one or more probes of 5′-GAGTGYCCMAARTAYGTSAAAT-3′ (SEQ ID NO: 1), 5′-CCYCARGGAGARACAAGR-3′ (SEQ ID NO: 4), 5′-CCYCAAAARGAAACAARA-3′ (SEQ ID NO: 6), 5′-CCYMAAARAGAARCAAGA-3′ (SEQ ID NO: 7), 5′-CCYCAAAGARCCACAARA-3′ (SEQ ID NO: 8), 5′-CCAGAGAATCCAAAGCCC-3′ (SEQ ID NO: 9), 5′-CCYCAAAGAAAAACAAGA-3 ‘(SEQ ID NO: 11) and 5’-CCYCAGAAGAARAAGAGA-3′ (SEQ ID NO: 13), wherein each of the one or more probes has a tail composed of 19T bases added on its 5′ end; and wherein Y is C or T, M is A or C, R is A or G, and S is C or G.

5. A method for detecting H5 avian influenza virus and pathotyping the detected H5 avian influenza virus as a low-pathogenic avian influenza virus (LPAIV) or a highly-pathogenic avian influenza virus (HPAIV) in a biological sample comprising:

(a) obtaining nucleic acid from the biological sample;

(b) contacting the nucleic acid with the microarray of claim 1 ; and

(c) detecting H5 avian influenza and pathotyping it as HPAIV when the nucleic acid hybridizes to the at least one probe of (v) or to only the at least one probe of (i); or detecting H5 avian influenza and pathotyping it as LPAIV when the nucleic acid hybridizes to the at least one probe of (ii), (iii), or (iv).

6. The method of claim 5 , wherein the nucleic acid obtained from the biological sample is RNA and the RNA is reverse transcribed into DNA and amplified by a PCR reaction prior to contacting.

7. The method of claim 6 , wherein primers SEQ ID NO: 15 and SEQ ID NO: 16 are used in the PCR reaction.

8. The method of claim 7 , wherein the primers are 5′ end-biotinylated.

9. The method of claim 5 , wherein the nucleic acid further comprises a label.

10. The method of claim 9 , wherein the label is a fluorescent label, a chemiluminescent label, a colored dye label, a radioactive label, a radiopaque label, a protein including an enzyme, a peptide or a ligand.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 23, 2014
From: WANG, LIH-CHIANN; HUANG, CHIEN-HAO; WANG, CHING-HO
To: NATIONAL TAIWAN UNIVERSITY
Reel/Frame 032958/0978 →
Continuity (1)
Related Publication 20150337398A1 · Nov 26, 2015